Press Releases and News

December 2007

Roger Frechette, Ph.D. MaxThera’s VP of Chemistry and R&D Operations contributed a paper entitled “New Developments in Antibacterial Drug R&D” to: Annual Reports in Medicinal Chemistry, 2007, Vol. 42, chapter 22, pages 349-364.

29 November 2007

Ania Knap, Ph.D., MaxThera’s President and CSO contributed to the Women entrepreneurs in Science and Technology (WEST) Discussion Panel on “Building and Funding a Company” - Broad Institute, Cambridge, MA.

13 March, 2007

Ania Knap, PhD, and Katya Tsaioun, PhD, of Apredica will present: “A Surer Path to IND: Early ADME-Tox Models for Reducing Downstream Risk of Drug Development” at the IBC Life Sciences Conference - From Discovery to IND, March 13 - 14, 2007, Sheraton Inner Harbor Hotel Baltimore, MD.

1 October 2006

MaxThera highlighted in the MassHighTech feature - The Pitch

15 August 2006

MaxThera Awarded Additional NIH Grant of $758,000

7 March 2006

Ania Knap, PhD, MaxThera’s President and CSO featured on the WallStreetReporter in an interview scheduled for 3/8/06 @ 10:00AM ET with Ian Roberts.

1 February 2006

MaxThera Awarded Additional NIH Grant of $600,000

27 October 2005

A Defensive Strategy

6 September 2005

MaxThera Making the Most of Anti-Bioterror Grant

16 May 2005

MaxThera Awarded NIH Grant of $1.45 Million; Completes Acquisition of Rights to Drug Discovery Assets for Infectious Diseases

8 November 2004

Springboard: New England 2004 Selects MaxThera, Inc to Present at 5^th Annual Forum Showcasing Women-Led Ventures

Please address questions or comments to: webmaster@maxthera.com